Korean Circulation Journal

  • 제54권8호
  • /
  • Pages.497-498
  • /
  • 2024
  • /
  • 1738-5520(pISSN)
  • /
  • 1738-5555(eISSN)
대한심장학회 (The Korean Society of Cardiology)
권호 표지
DOI QR코드

DOI QR Code

Brightening Your Vision With Fractional Flow Reserve and Intravascular Ultrasound

  • Jung-Joon Cha (Department of Cardiology, Cardiovascular Center, Korea University Anam Hospital, Korea University College of Medicine) ;
  • Soon Jun Hong (Department of Cardiology, Cardiovascular Center, Korea University Anam Hospital, Korea University College of Medicine)
  • 투고 : 2024.06.29
  • 심사 : 2024.07.01
  • 발행 : 2024.08.01
PDF 다운로드
⟨ 이전 논문 다음 논문 ⟩

초록

키워드

참고문헌

  1. Hannan EL, Zhong Y, Reddy P, et al. Percutaneous coronary intervention with and without intravascular ultrasound for patients with complex lesions: utilization, mortality, and target vessel revascularization. Circ Cardiovasc Interv 2022;15:e011687.
  2. Parikh RV, Liu G, Plomondon ME, et al. Utilization and outcomes of measuring fractional flow reserve in patients with stable ischemic heart disease. J Am Coll Cardiol 2020;75:409-19.
  3. Ahn SG, Lee SJ. Dose coronary angiography suffice for assessment of intermediate coronary stenosis? Korean Circ J 2019;49:1033-4.
  4. De Bruyne B, Fearon WF, Pijls NH, et al. Fractional flow reserve-guided PCI for stable coronary artery disease. N Engl J Med 2014;371:1208-17.
  5. Elgendy IY, Mahmoud AN, Elgendy AY, Bavry AA. Outcomes with intravascular ultrasound-guided stent implantation: a meta-analysis of randomized trials in the era of drug-eluting stents. Circ Cardiovasc Interv 2016;9:e003700.
  6. Shlofmitz E, Iantorno M, Waksman R. Restenosis of drug-eluting stents: a new classification system based on disease mechanism to guide treatment and state-of-the-art review. Circ Cardiovasc Interv 2019;12:e007023.
  7. Cha JJ, Kim D, Kim BK, et al. Association between angiographic and intravascular ultrasound optimizations after new-generation drug-eluting stent implantation and clinical outcomes. Coron Artery Dis 2021;32:541-8.
  8. Lee JH, Ahn SG, Jeon HS, et al. Discordance between angiographic assessment and fractional flow reserve or intravascular ultrasound in intermediate coronary lesions: a post-hoc analysis of the FLAVOUR trial. Korean Circ J 2024;54:485-96.
  9. Park SJ, Ahn JM, Kang DY, et al. Preventive percutaneous coronary intervention versus optimal medical therapy alone for the treatment of vulnerable atherosclerotic coronary plaques (PREVENT): a multicentre, open-label, randomised controlled trial. Lancet 2024;403:1753-65.
  10. Yang S, Koo BK. Coronary physiology-based approaches for plaque vulnerability: implications for risk prediction and treatment strategies. Korean Circ J 2023;53:581-93.